chr20-32434666-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015338.6(ASXL1):​c.1954G>A​(p.Gly652Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00672 in 1,602,238 control chromosomes in the GnomAD database, including 401 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G652G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0087 ( 35 hom., cov: 32)
Exomes 𝑓: 0.0065 ( 366 hom. )

Consequence

ASXL1
NM_015338.6 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7O:1

Conservation

PhyloP100: 0.730

Publications

29 publications found
Variant links:
Genes affected
ASXL1 (HGNC:18318): (ASXL transcriptional regulator 1) This gene is similar to the Drosophila additional sex combs gene, which encodes a chromatin-binding protein required for normal determination of segment identity in the developing embryo. The protein is a member of the Polycomb group of proteins, which are necessary for the maintenance of stable repression of homeotic and other loci. The protein is thought to disrupt chromatin in localized areas, enhancing transcription of certain genes while repressing the transcription of other genes. The protein encoded by this gene functions as a ligand-dependent co-activator for retinoic acid receptor in cooperation with nuclear receptor coactivator 1. Mutations in this gene are associated with myelodysplastic syndromes and chronic myelomonocytic leukemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
ASXL1 Gene-Disease associations (from GenCC):
  • Bohring-Opitz syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Illumina, ClinGen, Laboratory for Molecular Medicine, G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.001430273).
BP6
Variant 20-32434666-G-A is Benign according to our data. Variant chr20-32434666-G-A is described in CliVar as Benign. Clinvar id is 133592.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-32434666-G-A is described in CliVar as Benign. Clinvar id is 133592.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-32434666-G-A is described in CliVar as Benign. Clinvar id is 133592.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-32434666-G-A is described in CliVar as Benign. Clinvar id is 133592.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-32434666-G-A is described in CliVar as Benign. Clinvar id is 133592.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-32434666-G-A is described in CliVar as Benign. Clinvar id is 133592.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-32434666-G-A is described in CliVar as Benign. Clinvar id is 133592.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-32434666-G-A is described in CliVar as Benign. Clinvar id is 133592.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0656 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ASXL1NM_015338.6 linkc.1954G>A p.Gly652Ser missense_variant Exon 13 of 13 ENST00000375687.10 NP_056153.2 Q8IXJ9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ASXL1ENST00000375687.10 linkc.1954G>A p.Gly652Ser missense_variant Exon 13 of 13 5 NM_015338.6 ENSP00000364839.4 Q8IXJ9-1

Frequencies

GnomAD3 genomes
AF:
0.00870
AC:
1323
AN:
152112
Hom.:
32
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00200
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0360
Gnomad ASJ
AF:
0.00980
Gnomad EAS
AF:
0.0719
Gnomad SAS
AF:
0.00580
Gnomad FIN
AF:
0.0112
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00165
Gnomad OTH
AF:
0.0119
GnomAD2 exomes
AF:
0.0191
AC:
4317
AN:
225642
AF XY:
0.0155
show subpopulations
Gnomad AFR exome
AF:
0.00126
Gnomad AMR exome
AF:
0.0803
Gnomad ASJ exome
AF:
0.00741
Gnomad EAS exome
AF:
0.0624
Gnomad FIN exome
AF:
0.00959
Gnomad NFE exome
AF:
0.00235
Gnomad OTH exome
AF:
0.0176
GnomAD4 exome
AF:
0.00651
AC:
9435
AN:
1450008
Hom.:
366
Cov.:
30
AF XY:
0.00608
AC XY:
4382
AN XY:
720604
show subpopulations
African (AFR)
AF:
0.00112
AC:
37
AN:
33138
American (AMR)
AF:
0.0734
AC:
3173
AN:
43244
Ashkenazi Jewish (ASJ)
AF:
0.00762
AC:
198
AN:
25992
East Asian (EAS)
AF:
0.0938
AC:
3657
AN:
38970
South Asian (SAS)
AF:
0.00291
AC:
249
AN:
85480
European-Finnish (FIN)
AF:
0.0102
AC:
521
AN:
51222
Middle Eastern (MID)
AF:
0.00505
AC:
29
AN:
5748
European-Non Finnish (NFE)
AF:
0.000967
AC:
1070
AN:
1106362
Other (OTH)
AF:
0.00837
AC:
501
AN:
59852
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
605
1210
1814
2419
3024
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
126
252
378
504
630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00874
AC:
1330
AN:
152230
Hom.:
35
Cov.:
32
AF XY:
0.00956
AC XY:
712
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.00200
AC:
83
AN:
41536
American (AMR)
AF:
0.0367
AC:
561
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00980
AC:
34
AN:
3470
East Asian (EAS)
AF:
0.0716
AC:
370
AN:
5164
South Asian (SAS)
AF:
0.00560
AC:
27
AN:
4824
European-Finnish (FIN)
AF:
0.0112
AC:
119
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00165
AC:
112
AN:
68008
Other (OTH)
AF:
0.0113
AC:
24
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
71
142
213
284
355
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00480
Hom.:
46
Bravo
AF:
0.0118
ESP6500AA
AF:
0.00195
AC:
8
ESP6500EA
AF:
0.00208
AC:
17
ExAC
AF:
0.0154
AC:
1854
Asia WGS
AF:
0.0520
AC:
180
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2Other:1
Oct 06, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Bohring-Opitz syndrome Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
15
DANN
Benign
0.90
DEOGEN2
Benign
0.052
T;T;T;.;T
Eigen
Benign
-0.72
Eigen_PC
Benign
-0.56
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.72
.;T;.;T;T
MetaRNN
Benign
0.0014
T;T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.74
N;N;N;.;.
PhyloP100
0.73
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.51
N;.;.;.;N
REVEL
Benign
0.017
Sift
Benign
0.65
T;.;.;.;T
Sift4G
Benign
0.49
T;T;T;.;T
Polyphen
0.0040
B;B;B;.;.
Vest4
0.20
MPC
0.059
ClinPred
0.0027
T
GERP RS
2.0
RBP_binding_hub_radar
1.1
RBP_regulation_power_radar
4.0
Varity_R
0.042
gMVP
0.10
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3746609; hg19: chr20-31022469; COSMIC: COSV60103026; COSMIC: COSV60103026; API